Outcomes and care quality metrics for people living with rheumatic heart disease and atrial fibrillation in Uganda
- PMID: 38690140
- PMCID: PMC11056452
- DOI: 10.1016/j.hroo.2024.02.002
Outcomes and care quality metrics for people living with rheumatic heart disease and atrial fibrillation in Uganda
Abstract
Background: Atrial fibrillation (AF) is a common complication of rheumatic heart disease (RHD) and is challenging to treat in lower-resourced settings in which RHD remains endemic.
Objective: We characterized demographics, treatment outcomes, and factors leading to care retention for participants with RHD and AF in Uganda.
Methods: We conducted a retrospective analysis of the Uganda national RHD registry between June 2009 and May 2018. Participants with AF or atrial flutter were included. Demographics, survival, and care metrics were compared with participants without AF. Multivariable logistic regression was used to identify factors associated with retention in care among participants with AF.
Results: A total of 1530 participants with RHD were analyzed and 293 (19%) had AF. The median age was 24 (interquartile range 14-38) years. Mortality was similar in both groups (adjusted hazard ratio 1.183, P = .77) over a median follow-up of 203 (interquartile range 98-275) days. A total of 79% of AF participants were prescribed anticoagulation, and 43% were aware of their target international normalized ratio. Retention in care was higher in participants with AF (18% vs 12%, P < .01). Factors associated with decreased retention in care include New York Heart Association functional class III/IV (adjusted odds ratio [OR] 0.48, 95% confidence interval [CI] 0.30-0.76) and distance to nearest health center (adjusted OR 0.94, 95% CI 0.90-0.99). Anticoagulation prescription was associated with enhanced care retention (adjusted OR 1.86, 95% CI 1.24-2.79).
Conclusion: Participants with RHD and AF in Uganda do not experience higher mortality than those without AF. Anticoagulation prescription rates are high. Although retention in care is poor among RHD participants, those with concurrent AF are more likely to be retained.
Keywords: Atrial fibrillation; Global health; Outcomes; Retention in care; Rheumatic heart disease.
© 2024 Heart Rhythm Society. Published by Elsevier Inc.
Figures
Similar articles
-
Impact of renin-angiotensin system inhibitors on long-term clinical outcomes of patients with rheumatic heart disease.ESC Heart Fail. 2021 Dec;8(6):5338-5351. doi: 10.1002/ehf2.13623. Epub 2021 Sep 20. ESC Heart Fail. 2021. PMID: 34545695 Free PMC article.
-
Clinical Outcomes, Echocardiographic Findings, and Care Quality Metrics for People Living With Human Immunodeficiency Virus (HIV) and Rheumatic Heart Disease in Uganda.Clin Infect Dis. 2022 May 3;74(9):1543-1548. doi: 10.1093/cid/ciab681. Clin Infect Dis. 2022. PMID: 34382644
-
Prevalence, risk determinants and consequences of atrial fibrillation in rheumatic heart disease: 6 years hospital based-Himachal Pradesh- Rheumatic Fever/Rheumatic Heart Disease (HP-RF/RHD) Registry.Indian Heart J. 2018 Dec;70 Suppl 3(Suppl 3):S68-S73. doi: 10.1016/j.ihj.2018.05.013. Epub 2018 May 19. Indian Heart J. 2018. PMID: 30595324 Free PMC article.
-
Meta-Analysis of the Incidence, Prevalence, and Correlates of Atrial Fibrillation in Rheumatic Heart Disease.Glob Heart. 2020 May 18;15(1):38. doi: 10.5334/gh.807. Glob Heart. 2020. PMID: 32923332 Free PMC article. Review.
-
Long-term oral anticoagulation for atrial fibrillation in low and middle income countries.Indian Heart J. 2021 Mar-Apr;73(2):244-248. doi: 10.1016/j.ihj.2021.02.003. Epub 2021 Feb 10. Indian Heart J. 2021. PMID: 33865530 Free PMC article. Review.
Cited by
-
Providing medical care in health resource-constrained global areas: Syria.Heart Rhythm O2. 2024 Oct 24;5(12):860-861. doi: 10.1016/j.hroo.2024.10.009. eCollection 2024 Dec. Heart Rhythm O2. 2024. PMID: 39803624 Free PMC article. No abstract available.
-
State of the Journal 2025.Heart Rhythm O2. 2025 Jan 21;6(1):1-2. doi: 10.1016/j.hroo.2024.12.003. eCollection 2025 Jan. Heart Rhythm O2. 2025. PMID: 40224265 Free PMC article. No abstract available.
References
-
- Watkins D.A., Johnson C.O., Colquhoun S.M., et al. Global, regional, and national burden of rheumatic heart disease, 1990-2015. N Engl J Med. 2017;377:713–722. - PubMed
-
- Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983–988. - PubMed
LinkOut - more resources
Full Text Sources